Endostatin-Expressing Stem Cells: A New Approach to Treating Endometriosis

Endostatin-Expressing Stem Cells: A New Approach to Treating Endometriosis By Hakan Kula

Endometriosis is a chronic inflammatory condition characterized by abnormal blood vessel formation. Endostatin, a potent angiogenesis inhibitor, has shown potential in targeting the process of angiogenesis. In a study published in Stem Cells Translational Medicine,  Peng and Zhang et al. explored the therapeutic…

Key Points Lay Summary

Study Sheds Light on the Molecular Mechanism of Endometriosis Lesion Formation

Study Sheds Light on the Molecular Mechanism of Endometriosis Lesion Formation By Özge Özkaya

The production of a protein called Nucleotide-binding Oligomerization Domain 1 (NOD1) in ectopic mesenchymal stem cells may be associated with the formation of ectopic endometrial lesions, according to a new study published in the International Journal of Stem Cells. This…

Key Points Lay Summary

Endometriosis Development: Pathogenesis and genomics

Endometriosis Development: Pathogenesis and genomics By Selma Oransay

In this review recently published in the International Journal of Molecular Sciences, Baranow et al from Saint Petersburg, Russia,  hypothesize the existence of an endometriosis development genetic program (EMDP) that governs the origin of endometrium stem cells programmed for endometriosis; their transition…

Key Points Lay Summary

Mechanism for Migration of Endometriosis Cells in the Body

Mechanism for Migration of Endometriosis Cells in the Body By Kasthuri Nair

Li et al. recently published a paper in Stem Cells titled “Hematogenous Dissemination of Mesenchymal Stem Cells from Endometriosis.” This article seeks to understand the mechanisms underlying the migration of endometriosis. The authors initially hypothesize that endometriosis-derived mesenchymal stem cells…

Key Points Lay Summary

Human Endometrium-Derived Mesenchymal Stem Cells for Cell-based Therapies

Human Endometrium-Derived Mesenchymal Stem Cells for Cell-based Therapies By Yu Yu

Mesenchymal stem cells are a promising candidate for cell-based targeted therapies because they have characteristics such as self-renewal, multipotency, low immunogenicity, and non-oncogenicity. It has the capacity to migrate to sites of inflammation including in endometrial lesions and tumor. Most…

Key Points Lay Summary